Stock Scorecard
Stock Summary for Haleon plc (HLN) - $9.32 as of 5/8/2026 4:30:15 PM EST
Total Score
9 out of 30
Safety Score
36 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HLN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HLN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HLN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HLN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HLN (36 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for HLN
Financial Details for HLN
Company Overview |
|
|---|---|
| Ticker | HLN |
| Company Name | Haleon plc |
| Country | N/A |
| Description | Haleon plc (HLN) is a prominent global player in the consumer health sector, dedicated to providing innovative health solutions through its diverse portfolio, which includes renowned brands like Sensodyne, Panadol, and Voltaren. Established as a spin-off from GlaxoSmithKline, the company leverages its strong brand equity to cater to critical health segments such as oral care, pain relief, and dietary supplements. Committed to sustainability and consumer-centric innovation, Haleon is strategically positioned to enhance health outcomes worldwide while pursuing growth and generating value for its shareholders through targeted investments and continuous product development. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 7/30/2026 |
Stock Price History |
|
| Last Day Price | 9.32 |
| Price 4 Years Ago | 7.52 |
| Last Day Price Updated | 5/8/2026 4:30:15 PM EST |
| Last Day Volume | 25,406,760 |
| Average Daily Volume | 7,340,374 |
| 52-Week High | 11.20 |
| 52-Week Low | 8.60 |
| Last Price to 52 Week Low | 8.37% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 39.10 |
| Sector PE | 81.50 |
| 5-Year Average PE | 19.54 |
| Free Cash Flow Ratio | 31.07 |
| Industry Free Cash Flow Ratio | 10.13 |
| Sector Free Cash Flow Ratio | 24.59 |
| Current Ratio Most Recent Quarter | 0.92 |
| Total Cash Per Share | 0.30 |
| Book Value Per Share Most Recent Quarter | 5.01 |
| Price to Book Ratio | 1.88 |
| Industry Price to Book Ratio | 17.03 |
| Sector Price to Book Ratio | 9.97 |
| Price to Sales Ratio Twelve Trailing Months | 3.78 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.66 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.70 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 4,444,528,000 |
| Market Capitalization | 41,423,000,960 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/10/2026 |
| Previous Dividend Amount | 0.0598 |
| Current Dividend Amount | 0.1307 |
| Total Years Dividend Increasing | 3 |
| Trailing Annual Dividend Rate | 0.19 |
| Trailing Annual Dividend Yield | 2.06% |
| Forward Annual Dividend Rate | 0.26 |
| Forward Annual Dividend Yield | 2.83% |
| 5-Year Dividend Payments Count | 7 |
| 3-Year Average Dividend Yield | 1.85% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 41.81% |
| 3-Year Dividend Growth Rate Percentage | 19.09% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 33.32% |
| Dividend Payout Ratio | 38.10% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 92.00% |
| Annual Earnings Growth | 13.07% |
| Reported EPS 12 Trailing Months | 0.50 |
| Reported EPS Past Year | 0.34 |
| Reported EPS Prior Year | 10.59 |
| Net Income Twelve Trailing Months | 2,780,691,817 |
| Net Income Past Year | 1,630,468,421 |
| Net Income Prior Year | 1,442,000,000 |
| Quarterly Revenue Growth YOY | 0.60% |
| 5-Year Revenue Growth | 1.75% |
| Operating Margin Twelve Trailing Months | 23.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,321,672,815 |
| Total Cash Past Year | 1,321,672,815 |
| Total Cash Prior Year | 2,195,000,000 |
| Net Cash Position Most Recent Quarter | -6,341,327,185 |
| Net Cash Position Past Year | -6,341,327,185 |
| Long Term Debt Past Year | 7,663,000,000 |
| Long Term Debt Prior Year | 8,542,000,000 |
| Total Debt Most Recent Quarter | 7,663,000,000 |
| Equity to Debt Ratio Past Year | 0.68 |
| Equity to Debt Ratio Most Recent Quarter | 0.68 |
| Total Stockholder Equity Past Year | 16,396,129,908 |
| Total Stockholder Equity Prior Year | 16,166,000,000 |
| Total Stockholder Equity Most Recent Quarter | 16,396,129,908 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 4,738,673,098 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.07 |
| Free Cash Flow Past Year | 1,970,842,157 |
| Free Cash Flow Prior Year | 2,051,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.33 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 5/7/2026 12:52:26 AM EST |